46 related articles for article (PubMed ID: 27789282)
1. Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.
Vergara C; Thio CL; Johnson E; Kral AH; O'Brien TR; Goedert JJ; Mangia A; Piazzolla V; Mehta SH; Kirk GD; Kim AY; Lauer GM; Chung RT; Cox AL; Peters MG; Khakoo SI; Alric L; Cramp ME; Donfield SM; Edlin BR; Busch MP; Alexander G; Rosen HR; Murphy EL; Latanich R; Wojcik GL; Taub MA; Valencia A; Thomas DL; Duggal P
Gastroenterology; 2019 Apr; 156(5):1496-1507.e7. PubMed ID: 30593799
[TBL] [Abstract][Full Text] [Related]
2. How Ancestry Influences the Chances of Finding Unrelated Donors: An Investigation in Admixed Brazilians.
Nunes K; Aguiar VRC; Silva M; Sena AC; de Oliveira DCM; Dinardo CL; Kehdy FSG; Tarazona-Santos E; Rocha VG; Carneiro-Proietti ABF; Loureiro P; Flor-Park MV; Maximo C; Kelly S; Custer B; Weir BS; Sabino EC; Porto LC; Meyer D
Front Immunol; 2020; 11():584950. PubMed ID: 33240273
[TBL] [Abstract][Full Text] [Related]
3. Genomic ancestry and the social pathways leading to major depression in adulthood: the mediating effect of socioeconomic position and discrimination.
Loret de Mola C; Hartwig FP; Gonçalves H; Quevedo Lde A; Pinheiro R; Gigante DP; Motta JV; Pereira AC; Barros FC; Horta BL
BMC Psychiatry; 2016 Sep; 16(1):308. PubMed ID: 27596337
[TBL] [Abstract][Full Text] [Related]
4. Molecular frequency of human gemycircularvirus (GCYV) dna among blood donors from the Brazilian Amazon.
Breno Zampieri Lima M; Giovana Pereira Daniel T; Tayaná Oliveira Bitencourt H; Carlos Junior Alcantara L; Haddad R; Kashima S; Carolina Elias M; Giovanetti M; Coccuzzo Sampaio S; Nanev Slavov S
Transfus Clin Biol; 2024 May; 31(2):123-126. PubMed ID: 38280666
[No Abstract] [Full Text] [Related]
5. Association between IFNGR1 gene polymorphisms and tuberculosis susceptibility: A meta-analysis.
Cheng L; Zhang F; Wang Y; Chen J; Yuan X
Front Public Health; 2022; 10():976221. PubMed ID: 36148347
[TBL] [Abstract][Full Text] [Related]
6. Interferon-lambda 3 and 4 Polymorphisms Increase Sustained Virological Responses and Regulate Innate Immunity in Antiviral Therapy With Pegylated Interferon-Alpha.
da Silva AMV; Alvarado-Arnez LE; Azamor T; Batista-Silva LR; Leal-Calvo T; Bezerra OCL; Ribeiro-Alves M; Kehdy FSG; Neves PCDC; Bayma C; da Silva J; de Souza AF; Muller M; de Andrade EF; Andrade ACM; Dos Santos EM; Xavier JR; Maia MLS; Meireles RP; Cuni HN; Sander GB; Picon PD; Matos DCS; Moraes MO
Front Cell Infect Microbiol; 2021; 11():656393. PubMed ID: 34307188
[TBL] [Abstract][Full Text] [Related]
7. IFN-λ gene polymorphisms as predictive factors in chronic hepatitis C treatment-naive patients without access to protease inhibitors.
Olmedo DB; Cader SA; Porto LC
J Med Virol; 2015 Oct; 87(10):1702-15. PubMed ID: 25970604
[TBL] [Abstract][Full Text] [Related]
8. Cross-ancestry genomic research: time to close the gap.
Atkinson EG; Bianchi SB; Ye GY; Martínez-Magaña JJ; Tietz GE; Montalvo-Ortiz JL; Giusti-Rodriguez P; Palmer AA; Sanchez-Roige S
Neuropsychopharmacology; 2022 Sep; 47(10):1737-1738. PubMed ID: 35739257
[No Abstract] [Full Text] [Related]
9. Prevalence of IFNL3 gene polymorphism among blood donors and its relation to genomic profile of ancestry in Brazil.
Rizzo SR; Gazito D; Pott-Junior H; Latini FR; Castelo A
Braz J Infect Dis; 2016; 20(6):619-622. PubMed ID: 27789282
[TBL] [Abstract][Full Text] [Related]
10. Influence of IFNL3.rs12979860 and IFNL4.ss469415590 polymorphism on clearance of hepatitis C virus infection among Egyptians.
Knapp S; Zakaria Z; Hashem M; Zaghla H; Khakoo SI; Waked I; Thursz M; Abdelwahab SF
Hepatol Int; 2015 Apr; 9(2):251-7. PubMed ID: 25788203
[TBL] [Abstract][Full Text] [Related]
11. A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection.
Chang KC; Tseng PL; Wu YY; Hung HC; Huang CM; Lu SN; Wang JH; Lee CM; Chen CH; Tsai MC; Yen YH; Lin MT; Wu CK; Huang CC; Chen HH; Hu TH
Clin Gastroenterol Hepatol; 2015 May; 13(5):1017-24. PubMed ID: 25460552
[TBL] [Abstract][Full Text] [Related]
12. Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.
Wiegand SB; Heidrich B; Susser S; Rogalska-Taranta M; Petersen J; Böker KH; Grigorian N; Link R; Naumann U; John C; Lueth S; Malfertheiner P; Manns MP; Wedemeyer H; Sarrazin C; Cornberg M
PLoS One; 2015; 10(12):e0145622. PubMed ID: 26699619
[TBL] [Abstract][Full Text] [Related]
13. IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection.
Eslam M; Leung R; Romero-Gomez M; Mangia A; Irving WL; Sheridan D; Spengler U; Mollison L; Cheng W; Bugianesi E; McLeod D; Zaitoun AM; Attino V; Goeltz D; Nattermann J; Douglas M; Booth DR; George J; Ahlenstiel G
J Hepatol; 2014 Aug; 61(2):235-41. PubMed ID: 24768758
[TBL] [Abstract][Full Text] [Related]
14. IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients.
Zhang Q; Lapalus M; Asselah T; Laouénan C; Moucari R; Martinot-Peignoux M; Bieche I; Estrabaud E; De Muynck S; Boyer N; Bedossa P; Vidaud M; Marcellin P; Lada O
J Viral Hepat; 2014 Jul; 21(7):525-32. PubMed ID: 24118626
[TBL] [Abstract][Full Text] [Related]
15. Impact of IL28B, ITPA and PNPLA3 genetic variants on therapeutic outcome and progression of hepatitis C virus infection.
Rembeck K; Lagging M
Pharmacogenomics; 2015; 16(10):1179-88. PubMed ID: 26250055
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
